We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Amgen is acquiring Seattle, Wash.-based Rodeo Therapeutics in a move to broaden its reach in regenerative medicine, in a deal worth up to $721 million. Read More
Novavax has enlisted GlaxoSmithKline (GSK) to help it mass produce its promising COVID-19 vaccine in the UK as the inoculation draws closer to potential authorization. Read More
A group of House Democrats has called on the Federal Trade Commission (FTC) to begin an investigation into potential collusion between insulin makers Eli Lilly, Novo Nordisk and Sanofi to significantly raise the price of the lifesaving drug. Read More
As Novavax gears up to file for authorizations for its two-dose COVID-19 vaccine, the U.S. drugmaker has been working to significantly expand its manufacturing capabilities in Europe and other parts of the globe and believes it can supply well over 100 million doses a month by the fall. Read More
The company has entered into multiple manufacturing pacts aimed at ramping up production, including with Emergent BioSolutions, Catalent and Merck. Read More
Johnson & Johnson (J&J) said it expects to deliver 20 million doses of its COVID-19 vaccine for the U.S. by the end of March, as officials nationwide continued to complain of severely limited supplies of the single-shot vaccine. Read More
AbbVie has filed a lawsuit alleging that Iceland-based biosimilar developer Alvotech recruited a former AbbVie employee to steal trade secrets in order to produce a biosimilar of AbbVie’s blockbuster arthritis drug Humira (adalimumab). Read More